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Abstract
Introduction The goal of signal detection in pharma-
covigilance (PV) is to detect unknown causal associations
between medicines and unexpected events. Statistical
methods serve to detect signals and supplement traditional
PV methods. Statistical signal detection (SSD) requires
decisions about various settings that influence the quality
and efficiency of SSD, as shown in several studies. To our
knowledge, the effects of SSD periodicity and resignalling
criteria on the quality and workload of routine SSD have
not been published before.
Objective To analyse the effects of different periodicities
and resignalling criteria on signal detection quality and
signal validation workload, and to test the impact of
changing the signal threshold for number of cases.
Methods We calculated signals of disproportionate
reporting (SDRs) using thresholds of number of cases
(N) C3, proportional reporting ratio C2 and Chi2 C 4. We
retrospectively simulated recurrent SDR calculation and
validation with varying periodicity (quarterly vs. monthly),
resignalling criteria, and N C 3 vs. N C 5.
Results Changing the periodicity from quarterly to
monthly increased the workload by 46.6 % (0 % signal
loss). More restrictive resignalling criteria reduced the
workload between 36.3 % (0 % signal loss) and 74.1 %
(50 % signal loss). For N C 3, the most efficient monthly
SSD resignalling criterion reduced the workload by 36.3 %
and detected all true signals earlier than quarterly SSD.
N C 5 reduced the workload between 13.8 and 21.4 %
(0 % signal loss).
Conclusions In real-life PV practice, signal detection and
validation are recurrent periodic activities. Some true sig-
nals are only discovered upon resignalling. Our results
demonstrate resignalling criteria with high signal detection
quality and high efficiency. We found potential earlier
detection of true signals using monthly SSD. Additional
studies about resignalling should be performed to com-
plement our findings.
Key Points
Resignalling plays an important role in real-life
signal detection and validation practice.
Some true signals are only identified upon
resignalling.
Resignalling criteria should be selected carefully to
balance early detection of true signals with limiting
the workload for the validation of false-positive
signals.
1 Introduction
1.1 Statistical Signal Detection
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‘‘Information that arises from one or multiple sources
(including observations and experiments), which
suggests a new potentially causal association, or a
new aspect of a known association, between an
intervention and an event or set of related events,
either adverse or beneficial, that is judged to be of
sufficient likelihood to justify verificatory action’’
[1].
Following this definition, the goal of signal detection is
to identify new potentially causal associations, or new
aspects of known associations. Traditional methods of
signal detection include the review of scientific literature,
individual case safety reports (ICSRs, cases) including
‘‘index cases’’, the review of case series, Designated
Medical Events and Targeted Medical Events, and the
reviews performed during the creation of periodic aggre-
gate reports such as Periodic Safety Update Reports,
Periodic Benefit–Risk Evaluation Reports, Development
Safety Update Reports, Annual Safety Reports, Periodic
Adverse Drug Experience Reports and Investigational New
Drug Safety Reports [1].
To support and enhance the traditional methods, statis-
tical signal detection (SSD), e.g. using disproportionality
algorithms (DAs) such as the proportional reporting ratio
(PRR), has been added to the PV tool set to allow the
computer-supported screening of large safety databases [2].
The goal of SSD is to detect signals earlier than traditional
PV methods, and thereby gain time to start signal analysis
and risk mitigation actions earlier. Studies have shown that
this goal is indeed realistic, at least for a large proportion of
signals [3, 4]. Agreement exists about the general role of
SSD: it should be used to support, but not to replace, tra-
ditional PV methods [1, 5].
It is important to note that the initial result of SSD often is
not called ‘‘signal’’ but e.g. ‘‘Signal of Disproportionate
Reporting’’ (SDR) which requires the review by a safety
expert who puts such an SDR into clinical context and decides
if the SDR is a signal or not [6]. The definition of signal
validation, although not explicitly mentioning SDR, contains
the importance of review of the initial signal detection result:
‘‘Signal validation is the process of evaluating the
data supporting the detected signal in order to verify
that the available documentation contains sufficient
evidence demonstrating the existence of a new
potentially causal association or a new aspect of a
known association, and therefore justifies further
analysis’’ [5].
This means that SSD results need to be reviewed, and
this puts the burden of additional work on organisations
using SSD. When an organisation plans to implement SSD
as a periodic routine PV practice, it needs to decide on a
range of possible settings, e.g. the safety databases to be
screened, the periodicity of SSD calculations (‘‘signal
runs’’), one or several signal detection algorithms, and
signal thresholds. All of these parameters influence the
quality and efficiency of SSD. Quality is considered the
capability of SSD to detect true signals, or to detect true
signals earlier than traditional PV methods, respectively.
Efficiency can be viewed as the periodic or cumulative
workload put onto an organisation to perform the timely
review, or signal validation [5], of all SDRs generated by
the SSD system in relation to the ultimate goal of SSD:
earlier detected true signals. This workload can be mea-
sured as the total number of SDRs to be reviewed, or the
total number of SDRs per true signal detected early [3, 4].
In short, the real-life practice of signal detection and
management has to manage two potentially conflicting
goals: (1) quality: identify all true signals as early as pos-
sible, and (2) workload: let safety experts focus their pre-
cious time on the evaluation of true signals by reducing the
number of false-positive signals and thereby the work
needed to review them.
Several studies have compared safety databases, signal
detection algorithms and thresholds regarding quality
indicators such as sensitivity, specificity, and time to detect
true signals [7–13], while others explicitly focused on the
interrelated effects on quality and workload for variations
of signal thresholds and demonstrated ways to decrease the
workload efficiently while limiting the risk of missing true
signals [3, 4, 14].
1.2 Resignalling
The methods used in many studies (e.g. [3, 4, 14]) analyse
SSD as if an SDR for a specific product-event combination
(PEC) appears only once when it reaches the defined signal
threshold the first time, and at this point in time requires
work for signal validation, but the same PEC does never
appear as an SDR again, hence, each SDR-PEC only
requires signal validation once.
Although this might be enough for SDRs that are vali-
dated as being ‘‘signals’’ upon first appearance, many true
signals might be validated as ‘‘no signal’’ upon first
appearance, but safety information coming in later might
cross the ‘‘tipping point’’ where prior ‘‘no signals’’ turn
into ‘‘signals’’ requiring verificatory actions. Signal vali-
dation always is a point-in-time decision that might change
over time, and especially SDRs validated as ‘‘no signals’’
should be reevaluated, once new relevant safety informa-
tion becomes available. Hence, detecting new aspects of
prior ‘‘no signals’’ and of known causal associations, e.g.
increased frequency, increased severity, greater specificity
for selected patient populations or ‘‘striking’’ information
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about causality in new ICSRs, requires methods to bring
SDRs to the attention of safety experts again. One effective
method is to allow SDRs to reappear in the SSD system.
We call this reappearance ‘‘resignalling’’.
To our knowledge, there are no published recommen-
dations yet for the design and use of, what we call, ‘‘res-
ignalling criteria’’, i.e. conditions that need to be fulfilled
for a prior generated SDR to reappear. However, we have
found a few mentions of such criteria [1, 15] and have three
main options to approach resignalling:
• Full resignalling:
For each SSD run, all PECs that reach the signal
threshold are generated as SDRs, i.e. there is no check
if they have been generated (and validated) before in
prior SSD runs.
• Selective resignalling:
For each SSD run, all PECs that reach the signal
threshold are checked against prior SSD runs. If they
generated an SDR before, it is checked if they fulfill
predefined resignalling criteria (see Sect. 2.3). Only if
they reach the signal threshold plus fulfill the resig-
nalling criteria, are they generated again as SDRs
requiring validation.
Different options exist for the ‘‘baseline’’ the resig-
nalling criteria are tested against. The baseline can be:
• The properties (counts, frequencies, statistical
scores) an SDR had a predefined period ago, e.g.
‘‘in the previous week’’ [1], ‘‘26 weeks ago’’ or ‘‘52
weeks ago’’ [15];
• The properties an SDR had when it was validated
by a safety expert the last time.
The rationale for the latter option is: At this prior time,
a safety expert reviewed the SDR including its scores,
the available ICSRs and further safety information, e.g.
scientific literature, and made a point-in-time valida-
tion decision (‘‘signal’’ or ‘‘no signal’’). Then, only
relevant changes compared to this baseline, e.g. new
ICSRs, an increased PEC frequency, need to trigger the
reappearance of the same PEC for expert review.
• No resignalling:
A PEC is only generated as an SDR once and is never
generated again thereafter.
1.3 The Need for Evidence About Expected Quality
and Workload
Following the ‘‘Guideline on good pharmacovigilance
practices (GVP): Module IX Signal management’’ (GVP
Module IX), which recommends signal detection to be
performed at least monthly [5], we considered what the
most suitable periodicity of SSD could be, while tradi-
tional signal detection methods were already performed
as ongoing activities. As we were not aware of published
information about the effects of SSD periodicity on
signal detection quality and signal validation workload,
we decided to perform our own study and to compare
two SSD periodicities, quarterly and monthly. The study
needed to provide evidence about quality and workload,
and specifically answer the following questions: If,
compared to quarterly periodicity, SSD is performed
monthly,
• Would any true signal be missed?
• To what extent would the signal validation workload
increase?
• Are there options to maintain or decrease the workload,
while still detecting all true signals?
2 Methods
2.1 Data, Algorithms, Thresholds, and Periodicity
As data, we used spontaneous (including literature) reports
extracted from the company safety database, the charac-
teristics of which are published in Wisniewski et al. [15].
SDRs were calculated using the PRR in combination with
Chi2 (with Yates correction) with a signal threshold of
number of cases (N) C3, PRR C 2 and Chi2 C 4, as
described by Evans et al. [2]. In addition, we calculated the
95 % confidence interval for PRR as explained in the
‘‘Guideline on the use of statistical signal detection meth-
ods in the EudraVigilance data analysis system’’ [6].
Counts and statistics were calculated for suspect prod-
ucts for each PEC on the level of medicinal product name
and MedDRA1 Preferred Term. Both serious and non-
serious events were included. For some products, lists of
PECs, contained in the company core safety information
and/or for which other signal detection and monitoring
methods were implemented, were used to filter out corre-
sponding SDRs. The same filter was applied to both initial
and resignalled SDRs from all signal runs in this study to
avoid any time-related bias.
In our study, we compared quarterly vs. monthly SSD.
Inspired by Slattery et al. [4], we also evaluated the change
1 MedDRA (the Medical Dictionary for Regulatory Activities)
terminology is the international medical terminology developed under
the auspices of the International Conference on Harmonisation of
Technical Requirements for Registration of Pharmaceuticals for
Human Use (ICH). The MedDRA trademark is owned by the
International Federation of Pharmaceutical Manufacturers and Asso-
ciations on behalf of ICH.
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in the signal threshold for number of cases from N C 3 to
N C 5.
2.2 Reference Set of True Signals
To evaluate the signal detection quality, we used a reference
set of true signals. For this study, we defined ‘‘true signal’’ as
a PEC for which an SDR had been generated in the pro-
ductive SSD system, and which had undergone signal vali-
dation by a safety expert who assessed this SDR to be a signal
requiring verificatory action. We included only those SDRs
that were validated as signals the first time within the year
preceding the study, i.e. the same 1-year period we used in
our simulation. The reference set contained eight true sig-
nals, including four that appeared as new SDRs the first time
and four that had appeared before and were validated as ‘‘no
signal’’ at first, but appeared again upon resignalling and
were validated as ‘‘signal’’ then.
2.3 Resignalling Criteria
As mentioned earlier, we are not aware of any published
recommendation for the design and use of resignalling
criteria. However, we found examples of how other
organisations combined signal thresholds with time-de-
pendent criteria:
• ‘‘at least 3 reports of the [PEC] with 1 report received in
the previous week’’ [1].
• ‘‘EB05 C 1.8, and/or [positive] trend flag. A trend flag
is [positive] if either of the following are true:
– ‘‘An EB05 based on current data is[EB95 for the
[PEC] 52 weeks ago’’;
– ‘‘A 50 % increase in EBGM score when current
data are compared with the EBGM score 26 weeks
ago’’ [15].
Recently, Candore et al. also reported on these criteria
[13].
• ‘‘EB05[ 2 for non-serious unlisted adverse events;
any event whose reporting rate has increased signifi-
cantly compared to 6 months previously’’ [15].
(EBGM: Empirical Bayes Geometric Mean; EB05,
EB95: lower and upper bound of the 90 % confidence
interval for EBGM)
Building on these ideas, our previous experience with
SSD and resignalling, and using common sense about what
type of relevant new information could change the signal
validation decision and therefore should be brought to the
attention of the safety expert again, we designed a range of
different resignalling criteria for this study as follows:
If an SDR had been validated before (as ‘‘signal’’ or ‘‘no
signal’’), a new SDR for the same PEC is generated, if the
PEC reaches the signal threshold and if:
• Nnew C Nvalidated ? 1 (‘‘?1 new case’’):
At least one more case containing the PEC was added
to the safety database compared to the number of cases
at the time the SDR was validated previously.
• Nnew[Nvalidated ? 50 % (‘‘[50 % new cases’’):
The current number of cases for the PEC exceeds the
number of cases at the time the SDR was validated
previously by more than 50 %.
• Frequency (cumulative)new[ Frequency (cumula-
tive)validated ? 50 % (‘‘[50 % increased cumulative
frequency’’):
The current cumulative PEC frequency (= cumulative
number of cases for PEC/cumulative number of cases
for product) exceeds the cumulative PEC frequency at
the time the SDR was validated previously by more
than 50 %.
• Frequency (period)new[Frequency (period)vali-
dated ? 50 % (‘‘[50 % increased period frequency’’):
The current period-based PEC frequency (= number of
cases for PEC in the current SSD period/number of
cases for product in the current SSD period) exceeds
the period-based PEC frequency at the time the SDR
was validated previously by more than 50 %.
• PRRnew[ PRRvalidated ? 50 % (‘‘[50% increased
PRR’’):
The current PRR value exceeds the PRR value at the
time the SDR was validated previously by more than
50 %.
• PRR025new[ PRR975validated (‘‘PRR CI shift’’):
The current lower bound of the 95 % PRR confidence
interval (CI) (PRR025) exceeds the upper bound of the
95 % PRR CI (PRR975) at the time the SDR was
validated previously.
• No resignalling:
For a given PEC, an SDR is only generated when it
reaches the signal threshold the first time and does
never reappear as SDR thereafter.
Figure 1 illustrates, for one PEC, the monthly counts,
frequencies and PRR scores used for the different resig-
nalling criteria from the initial appearance as SDR in the
baseline SSD run over the course of the 1-year study per-
iod. The figure also shows for each resignalling criterion in
which month(s) the PEC reappears as SDR. As an example,
the flashes in Fig. 1 indicate when the PEC is detected as
SDR the first time and reappears again as SDR for the
resignalling criterion ‘‘[50 % increased period
frequency’’.
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Fig. 1 Top and middle case counts, frequencies and proportional
reporting ratio (PRR) with 95 % confidence interval (CI) for a selected
product-event combination (PEC) from the baseline statistical signal
detection (SSD) run over the course of the study period. Middle as
example, the flashes indicate when the PEC is detected as signal of
disproportionate reporting (SDR) the first time and reappears again as
SDR for the resignalling criterion ‘‘[50 % increased period frequency’’
(signal threshold: N C 3, PRR C 2 and Chi2 C 4). Bottom an x in the
table denotes in which month(s) the PEC is detected as SDR for each
resignalling criterion
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2.4 Outcome Measures
With this study, we aimed to gather estimates about SSD
quality and workload.
To assess quality, we used three outcome measures:
(a) Cumulative total number of true signals detected:
The total number per resignalling criterion includes
both the signals identified by the respective resig-
nalling criterion and the new signals that reached the
signal threshold the first time during the study period.
(b) Percentage of change of (a) named ‘‘signal loss’’
compared with the reference set of SDRs validated as
signals2.
(c) Time of first detection compared with the reference
set of SDRs validated as signals and expressed as
‘‘earlier’’, ‘‘same time’’ or ‘‘later’’.
Others have used alternative quality measures: Alvarez
et al. and Slattery et al. computed the time gain of SSD for
detecting signals, which led to updates of the European
Union Summary of Product Characteristics compared with
detection by traditional PV methods [3, 4]; Hochberg et al.
compared SSD results against a ‘‘highly inclusive reference
event database’’ and calculated the number of SDRs nee-
ded to detect new true signals [12]; Candore et al. calcu-
lated the sensitivity and precision of SSD against a
reference set of PECs listed in the Summary of Product
Characteristics and company core safety information [13].
Being aware of those alternatives, we decided to use a
reference set of true signals that was created prospectively
during the real-life process of validating SDRs generated
by the SSD system. The advantage: We could be sure that
these signals were based on SSD and knew exactly when
they were first validated as signals (‘‘index dates’’), i.e. we
did not need to retrospectively identify the signal detection
sources (SSD vs. non-SSD) and index dates for the PECs in
our reference set, an approach that could have been prone
to bias owing to the retrospective approach. With this
prospective SSD-based reference set, we had the ideal
benchmark for the, now retrospective, SSD simulation,
which covered the same time period the true signals were
identified. As the number of true signals in the reference set
was small (eight PECs), we chose to use simple measures
rather than measures better suited for larger sample sizes,
such as sensitivity, specificity or precision.
To assess workload, we used two outcome measures:
(a) Cumulative total number of SDRs:
The total number per resignalling criterion includes
both the resignalling SDRs identified by the respec-
tive resignalling criterion and the new SDRs that
reached the signal threshold the first time during the
study period.
(b) Percentage of change of (a) compared with the total
number of SDRs for the initial SSD settings (quarterly
SSD runs, signal threshold for number of cases
(N) C3, resignalling criterion ‘‘?1 new case’’).
2.5 Simulation
We were interested how changes in the settings of the SSD
system affect the quality and workload of SSD. As we
wanted to get answers quickly, it would not have been
useful to apply the changes to the productive SSD system
because it would have taken a long time to get results for
the various possible combinations of settings. Furthermore,
we wanted to compare the SSD quality with a reference set
of SDRs that had already been assessed as being signals
during signal validation in real life and we needed to per-
form SSD runs for the same time period the validations had
been done.
To suit our needs, we decided to perform a simulation:
In June 2013, we simulated the recurrent SDR calculation
and signal validation for a retrospective 1-year period
while varying the settings for periodicity, resignalling cri-
teria and signal threshold for number of cases. The simu-
lation involved the following steps:
• SDRs were calculated for an initial quarterly (Q2 2012)
and an initial monthly (April 2012) SSD run. These
runs were used to simulate the cumulative history of
SSD runs up to this point where all SDRs generated in
this ‘‘seed run’’ would have been reviewed by safety
experts during signal validation. All subsequent SSD
runs could then use this signal validation history and
only bring up new SDRs for PECs that had not been
identified as SDRs before plus SDRs for PECs, which
had been generated and validated as SDRs before, but
reached the signal threshold again and fulfilled the
respective resignalling criteria.
• After that, SDRs were calculated for a period of
12 months for quarterly (Q3 2012 to Q2 2013, i.e. four
quarterly runs) andmonthly (May 2012 toApril 2013, i.e.
12 monthly runs) SSD periodicity. New SDRs and
resignalling SDRs resulting from each of these runs
were assumed to have been validated before the next run,
hence, their counts, frequencies and statistical scores
created a new baseline for the subsequent SSD runs to
compare the resignalling criteria against.
2 Also possible, but beyond the scope of this study, would be ‘‘signal
gains’’, i.e. SDRs identified and validated as signals in addition to the
SDRs which actually had gone through signal validation, had been
validated as signals and thereby made it into the reference set we used
in this study.
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• The SDRs resulting from all SSD runs were summed up
to get the cumulative total number of SDRs, which was
used as our measure for workload.
• Regarding quality, the SDRs resulting from any of the
SSD runs were checked against our reference set of true
signals.
In the simulation described above, we computed and
analysed the number of true signals detected. As we also
wanted to compare the times of first detection of these true
signals, we repeated the simulation using data for the same
study period but from a database snapshot that had been
updated since the first simulation. Using the data from this
new simulation, the index date for each true signal was
defined as the time of first detection with the initial SSD
system settings, i.e. quarterly SSD runs, signal threshold
N C 3, PRR C 2 and Chi2 C 4, and resignalling criterion
‘‘?1 new case’’. Then, the time of first detection for each
true signal and for each SSD setting was calculated,
compared against the index date, and the values of interest
assigned, i.e. ‘‘earlier’’, ‘‘same time’’ or ‘‘later’’,
respectively.
3 Results
3.1 Monthly vs. Quarterly Periodicity
Our initial question was: If we leave the other SSD settings
the same (i.e. signal threshold: N C 3, PRR C 2 and
Chi2 C 4; resignalling criterion: ‘‘?1 new case’’), how
would the workload for signal validation increase if we
move from quarterly to monthly SSD runs?
Figure 2 shows that the number of SDRs per monthly
SSD run is well below the ones for quarterly SSD runs.
However, looking at the ‘‘running total’’, i.e. the accu-
mulating number of SDRs from month to month, or quarter
to quarter, respectively, we immediately see a workload
increase of monthly compared with quarterly SSD (see
Fig. 3).
Looking at the numbers (see Table 1), changing the
periodicity from quarterly to monthly SSD, while keeping
the resignalling criterion ‘‘?1 new case’’, increased the
workload (cumulative total number of SDRs) by 46.6 %
with 0 % signal loss.
3.2 Comparing Resignalling Criteria
Comparing the effects of all resignalling criteria while
keeping the signal threshold for number of cases N C 3, we
got the following results:
• For quarterly SSD runs, the workload decrease ranges
from 49.1 % (12.5 % signal loss) to 75.0 % (50.0 %
signal loss).
• For monthly SSD runs, the workload change ranges
from a 46.6 % increase (0.0 % signal loss) to a 74.1 %
decrease (50.0 % signal loss).
• For N C 3, the most efficient resignalling criterion with
0.0 % signal loss is ‘‘[50 % increased period fre-
quency’’ using monthly SSD runs with a workload
decrease of 36.3 %.
As a visual summary, Fig. 4 shows the huge variations
in workload for the different resignalling criteria. Com-
pared with the baseline settings of the SSD system (6085
SDRs), when switching from quarterly to monthly SSD
runs, the workload change ranges from 8923 SDRs
(?46.6 %) to 1578 SDRs (-74.1 %). Considering also our
prerequisite of not missing any true signal, we see the least
workload for resignalling criterion ‘‘[50 % period fre-
quency increase’’ (3878 SDRs, -36.3 %).
3.3 Threshold N ‡ 5 vs. N ‡ 3
Applying a signal threshold of N C 5, results were as
follows:
• For quarterly SSD runs, the workload decrease ranges
from 13.8 % (0.0 % signal loss) to 83.3 % (37.5 %
signal loss).
• For monthly SSD runs, the workload change ranges
from a 32.0 % increase (0.0 % signal loss) to a 82.8 %
decrease (37.5 % signal loss).
• For N C 5, the most efficient resignalling criterion with
0.0 % signal loss is, just like for N C 3, ‘‘[50 %
increased period frequency’’ using monthly SSD runs
with a workload decrease of 49.9 %.
If we compare N C 5 with N C 3 for the initial SSD
settings (quarterly SSD runs, ‘‘?1 new case’’), N C 5
decreased the workload by 13.8 % with 0.0 % signal loss.
For the most efficient resignalling criterion for N C 3
(monthly SSD runs, 3878 SDRs, 36.3 % workload
decrease, 0.0 % signal loss), a switch to N C 5 (3047
SDRs) would additionally decrease the workload by
21.4 % with 0.0 % signal loss.
3.4 Completeness and Timeliness of Detecting True
Signals
Table 2 presents the results of our second simulation run
where we calculated and compared the dates of the first
detection of true signals (see Sect. 2.5).
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Comparing monthly with quarterly SSD runs for each
resignalling criterion, we see a consistent pattern of earlier
detection of true signals with monthly SSD.
Independent of settings for periodicity (quarterly vs.
monthly) and signal threshold (N C 3 vs. N C 5), the re-
signalling criteria seem to form a ‘‘quality hierarchy’’ when
we sort them from low to high signal loss (0.0–57.1 %),
while, from top to bottom, before losing signals, they first
tend to detect signals later:
1. ‘‘?1 new case’’
2. ‘‘[50 % increased period frequency’’
3. ‘‘[50 % new cases’’
4. ‘‘[50 % increased cumulative frequency’’ same qual-
ity as ‘‘[50 % increased PRR’’
5. ‘‘PRR025new[ PRR975validated’’ same quality as
‘‘Only new SDRs, no resignalling’’
‘‘?1 new case’’ is the only criterion with 0.0 % signal
loss for monthly and quarterly SSD runs with both N C 3
and N C 5.
The two best overall SSD settings regarding 0.0 %
signal loss and earlier detection of all true signals are
monthly SSD runs with signal threshold N C 3 and with
either ‘‘?1 new case’’ or ‘‘[50 % increased period
frequency’’.
4 Discussion
4.1 Monthly vs. Quarterly Periodicity
Our main question was: how much more SDRs have to be
reviewed during signal validation when SSD is performed
monthly compared with quarterly. If a SSD system would,
for any PEC, only generate an SDR the very first time it
reaches the signal threshold, and never again afterwards,
then the change of periodicity would, in general, not
increase the total number of SDRs.
An exception, we found, are SDRs that are only visible
in monthly SSD runs and are not detected in quarterly runs.
The likely cause for this phenomenon is this: In our study,
the PRR is based on the cumulative counts of ICSRs up to
specific ‘‘as of’’ dates (end of the month, end of the quar-
ter). Using these counts, the ‘‘PRR is an estimate of the
probability that a spontaneous report containing a product
(X) will mention an adverse event (Y) divided by the
Fig. 2 Number of signals of disproportionate reporting (SDRs) for
quarterly vs. monthly statistical signal detection (SSD) runs using
proportional reporting ratio (PRR) and resignalling criterion ‘‘?1 new
case’’ per SSD run over the 1-year study period (signal threshold:
N C 3, PRR C 2, Chi2 C 4). Note: The display of the quarterly SSD
results has been shifted by 15 days into the following month for
visualisation purposes
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probability that a report not containing X will mention Y’’
[4]. However, the content of a safety database is dynamic,
and ICSRs are added and updated all the time. Hence, the
ICSR counts by product, by adverse event and in total
change over time, and, therefore, the PRR changes
dynamically, too. The same is true for the Chi2. As a
consequence, PRR and Chi2 can reach the signal threshold
in a monthly SSD run, but may not reach the threshold in a
quarterly SSD run. These exceptions account for only a
small proportion of the total number of SDRs: We found 56
additional SDRs for the signal threshold N C 3, and 34 for
N C 5. These additional SDRs are contained in the
monthly runs for all resignalling criteria, so account for a
portion of the difference between monthly and quarterly
SSD runs. To analyse any potential ‘‘signal gain’’, i.e.
additional SDRs validated as ‘‘signals’’, among such SDRs
could be subject of a future study.
Interestingly, although the reference set of true signals
contained eight PECs, which all were found in the first
simulation (see Table 1), now, only seven were identi-
fied with the baseline SSD settings in the second simu-
lation (see Table 2), i.e. one true signal was lost. The
reason: One case containing the PEC of this true signal
had been identified as a duplicate after the first simula-
tion, and was excluded in the second simulation. With
one case less, this PEC did not reach the signal threshold
in any of the quarterly SSD runs, including the baseline
SSD settings, and, hence, was excluded from the results
in Table 2.
However, this true signal was still found as a new SDR
with monthly SSD runs in the second simulation, specifi-
cally, earlier than it was identified with quarterly SSD runs
in the data used in the first simulation. If we would want to
acknowledge this fact in Table 2, the number of signals
found ‘‘Earlier’’ for all resignalling criteria for monthly
SSD runs would increase by one, thus, further amplifying
the effect of earlier detection with monthly compared with
quarterly SSD.
Despite the difference of 7 vs. 8 signals, and considering
the known root cause for this observation, our second
simulation (Table 2) verifies the results of our first simu-
lation (Table 1), as the difference in ‘‘# signals found’’ is
consistently one signal less in Table 2 for each tested SSD
setting.
Fig. 3 Running total of number of signals of disproportionate
reporting (SDRs) for quarterly vs. monthly statistical signal detection
(SSD) runs using proportional reporting ratio (PRR) and resignalling
criterion ‘‘?1 new case’’ over the 1-year study period (signal
threshold: N C 3, PRR C 2, Chi2 C 4). Note: The display of the
quarterly SSD results has been shifted by 15 days into the following
month for visualisation purposes
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4.2 Effects of Resignalling
Beyond these exceptions, the more important question is, if
the SSD system allows SDRs to reappear, what we call
‘‘resignalling’’. If resignalling is disabled and only first-
time new SDRs are generated, then obviously the total
number of SDRs and the total workload required for signal
validation is much less than in a system with resignalling
enabled. In our study, new SDRs accounted for only 1014
(16.7 %; quarterly runs, N C 5) to 1578 (25.9 %; monthly
runs, N C 3) SDRs compared with the initial system set-
tings (6085 SDRs).
We recommend to enable resignalling in the SSD sys-
tem and consider it an important feature for detecting new
aspects of known associations and for revalidating SDRs in
the light of newly available safety information. As evi-
dence of this importance, when we created the reference
list of true signals, we found that four of eight SDRs val-
idated as ‘‘signal’’ had initially been assessed as ‘‘no sig-
nal’’ and turned from ‘‘no signal’’ to ‘‘signal’’ upon
resignalling. That means, without resignalling, 50 % of
these true signals would have been missed. That does not
necessarily mean they would have been missed completely,
as traditional signal detection methods make up for this
gap, detecting many signals even earlier or at about the
same time as SSD [3].
Regarding resignalling, the question was not ‘‘if’’, but
‘‘to what extent’’ it is useful. To answer this question,
besides comparing quarterly and monthly SSD periodicity,
we simulated the effect of the different resignalling criteria.
The simulation provided important answers:
• SSD can be performed with a monthly periodicity to
align with recommendations in GVP Module IX [5]
with options, compared with quarterly periodicity, to
decrease the signal validation workload and, at the
same time, improve the signal detection quality.
• Switching from the initially used resignalling criterion
‘‘?1 new case’’ to ‘‘[50 % increased period fre-
quency’’ decreased the workload by 36.3 % and still
detected all true signals.
• As an additional benefit, with monthly periodicity and
the new resignalling criterion, all true signals were
detected as SDRs earlier.
Table 1 Cumulative total number of SDRs generated in the study
period, percentage of difference compared with the baseline, number
of true signals found and percentage of signal loss compared with the
baseline. SDRs were generated using PRR with a signal threshold
PRR C 2 and Chi2 C 4, using quarterly vs. monthly SSD runs, signal
threshold N C 3 vs. N C 5, and different resignalling criteria


















?1 new casea 6085 8 8923 ?46.6 8 0.0
[50 % increased period
frequency
3096 -49.1 7 12.5 3878 -36.3 8 0.0
[50 % new cases 2140 -64.8 6 25.0 2355 -61.3 6 25.0
[50 % increased cumulative
frequency
1790 -70.6 5 37.5 1956 -67.9 5 37.5
[50 % increased PRR 1681 -72.4 5 37.5 1795 -70.5 5 37.5
PRR025new[PRR975validated 1551 -74.5 4 50.0 1611 -73.5 4 50.0
Only new SDRs, no resignalling 1522 -75.0 4 50.0 1578 -74.1 4 50.0
N C 5
?1 new case 5245 -13.8 8 0.0 8031 ?32.0 8 0.0
[50 % increased period
frequency
2341 -61.5 7 12.5 3047 -49.9 8 0.0
[50 % new cases 1438 -76.4 6 25.0 1597 -73.8 6 25.0
[50 % increased cumulative
frequency
1179 -80.6 6 25.0 1296 -78.7 6 25.0
[50 % increased PRR 1099 -81.9 6 25.0 1168 -80.8 6 25.0
PRR025new[PRR975validated 1043 -82.9 5 37.5 1080 -82.3 5 37.5
Only new SDRs, no resignalling 1014 -83.3 5 37.5 1048 -82.8 5 37.5
SDR signal of disproportionate reporting, PRR proportional reporting ratio, SSD statistical signal detection, N number of cases, # total number
a This setting is used as the baseline for comparison: Quarterly SSD runs, N C 3, resignalling criterion ‘‘?1 new case’’
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4.3 Threshold N ‡ 5 vs. N ‡ 3
As one of our objectives, we also wanted to test results by
Slattery et al. who also focussed on SSD quality and
workload and found, for the EudraVigilance Data Analysis
System, that a threshold of N C 5 compared with N C 3
‘‘gave a reduction of 25 % in false-positive signals in
return for a loss of 12 % in true signals detected early’’ [4].
Despite differences regarding the safety databases (Eu-
draVigilance vs. company database), signal thresholds
(lower bound of the 95 % confidence interval for PRR[ 1
vs. PRR C 2 and Chi2 C 4), and different signal reference
sets and quality measures, our results support their
findings:
• A threshold of N C 5 compared with N C 3 with
quarterly SSD runs and the initial resignalling criterion
‘‘?1 new case’’ reduced the workload by 13.8 % with
0.0 % signal loss.
• For the most efficient resignalling criterion (‘‘[50 %
increased period frequency, monthly SSD runs, 3878
SDRs, 0.0 % signal loss), a switch from N C 3 to
N C 5 (3047 SDRs) additionally reduced the workload
by 21.4 % with 0.0 % signal loss, but one true signal
(14.3 %) was detected later compared with N C 3.
4.4 Insights from Simulations
Resignalling criteria should be selected carefully to balance
a high signal detection quality (early detection of true
signals) with a high efficiency (minimum workload for
false-positive signals). Simulations, like the one we
described in this paper, are helpful to gather evidence about
the effects of different settings before applying any chan-
ges to the productive SSD system.
With this study, we obtained evidence that supports
performing SSD with a monthly periodicity and using a
resignalling criterion that (a) would not compromise on
quality, the early detection of true signals, and (b) would
decrease the workload for false-positive signals compared
with other SSD settings. Furthermore, we found a time gain
for earlier detection of true signals when using monthly
instead of quarterly SSD, if appropriate resignalling criteria
are used.
Finally, numerous factors influence the composition of a
safety database and its changes over time, e.g. addition of
case reports for new or newly acquired medicinal products
including new product classes, or case reports from
emerging sources such as social media. Safety database
changes, in turn, might affect the quality and efficiency of
SSD. Hence, whenever substantial database changes with a
Fig. 4 Cumulative total number of signals of disproportionate
reporting (SDRs) detected for quarterly vs. monthly statistical signal
detection (SSD) runs using proportional reporting ratio (PRR) and
different resignalling criteria (signal threshold: N C 3, PRR C 2,
Chi2 C 4). An asterisk on the bar signifies results where all true
signals were detected
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potential impact on SSD are occurring, reevaluation of the
SSD performance is warranted.
5 Conclusions
In real-life routine PV practice, signal detection and vali-
dation are recurrent periodic activities within the overall
signal management process. Resignalling is an important
feature of this process, as some true signals are only dis-
covered upon resignalling. The benefit of enabling resig-
nalling is the detection of true signals which only are
validated as signals upon resignalling. Within the study
period, we found that 50 % true signals were only identi-
fied during resignalling, hence, disabling resignalling
would mean a high risk of missing true signals. Based on
these findings, we suggest that resignalling should be
enabled in any complete SSD system. Enabling resig-
nalling, however, comes with an organisational ‘‘cost’’ of
an increased workload for signal validation. Fortunately,
we were able to identify resignalling criteria that limit this
workload increase while still finding all true signals.
Our reference set of true signals was rather small and
specific to our study objective and methods. To derive
general recommendations about resignalling and to com-
plement our findings, it would be worthwhile to study the
effects of resignalling in other safety databases, with other
signal detection algorithms, signal thresholds and bigger
signal reference sets.
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